Day 2 of San Francisco’s 2019 J.P. Morgan Healthcare Conference brought with it some notable announcements, and Scrip was there to report on the day’s most important news. Discover all of the essential developments from Day 2, including updates on Amgen deal making, new competition from Biohaven for Allergen’s stronghold on the migraine headache space, highlights from Commissioner Scott Gottlieb’s keynote address, and updates from Roche, GSK, and more. Tap into the vital news from Day 2 of the J.P. Morgan Healthcare Conference, as delivered by the experts from Scrip.